Enzo Biochem Inc (ENZ)
1.19
+0.03
(+2.59%)
USD |
NYSE |
May 31, 16:00
1.21
+0.02
(+1.68%)
Pre-Market: 20:00
Enzo Biochem Revenue (Quarterly): 8.553M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 8.553M |
| October 31, 2023 | 7.806M |
| July 31, 2023 | -19.66M |
| April 30, 2023 | 16.11M |
| January 31, 2023 | 7.514M |
| October 31, 2022 | 7.103M |
| July 31, 2022 | -54.14M |
| April 30, 2022 | 26.22M |
| January 31, 2022 | 34.05M |
| October 31, 2021 | 26.52M |
| July 31, 2021 | 24.81M |
| April 30, 2021 | 32.80M |
| January 31, 2021 | 31.47M |
| October 31, 2020 | 28.66M |
| July 31, 2020 | 19.53M |
| April 30, 2020 | 16.90M |
| January 31, 2020 | 19.38M |
| October 31, 2019 | 20.21M |
| July 31, 2019 | 20.92M |
| April 30, 2019 | 19.66M |
| January 31, 2019 | 19.33M |
| October 31, 2018 | 21.26M |
| July 31, 2018 | 22.76M |
| April 30, 2018 | 25.23M |
| January 31, 2018 | 26.15M |
| Date | Value |
|---|---|
| October 31, 2017 | 26.88M |
| July 31, 2017 | 25.45M |
| April 30, 2017 | 27.09M |
| January 31, 2017 | 26.26M |
| October 31, 2016 | 26.28M |
| July 31, 2016 | 26.60M |
| April 30, 2016 | 26.43M |
| January 31, 2016 | 24.56M |
| October 31, 2015 | 25.18M |
| July 31, 2015 | 25.70M |
| April 30, 2015 | 23.99M |
| January 31, 2015 | 23.09M |
| October 31, 2014 | 24.82M |
| July 31, 2014 | 24.91M |
| April 30, 2014 | 23.98M |
| January 31, 2014 | 22.93M |
| October 31, 2013 | 24.13M |
| July 31, 2013 | 23.27M |
| April 30, 2013 | 22.60M |
| January 31, 2013 | 22.21M |
| October 31, 2012 | 25.63M |
| July 31, 2012 | 26.41M |
| April 30, 2012 | 25.95M |
| January 31, 2012 | 24.97M |
| October 31, 2011 | 25.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-54.14M
Minimum
Jul 2022
34.05M
Maximum
Jan 2022
14.46M
Average
19.53M
Median
Jul 2020
Revenue (Quarterly) Benchmarks
| Delcath Systems Inc | 3.139M |
| Star Equity Holdings Inc | 9.118M |
| Exact Sciences Corp | 637.52M |
| CytoSorbents Corp | 8.990M |
| Progyny Inc | 278.08M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.061M |
| Total Expenses (Quarterly) | 9.977M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | 4.252M |
| Gross Profit Margin (Quarterly) | 49.39% |
| Profit Margin (Quarterly) | -35.79% |
| Earnings Yield | 56.30% |
| Normalized Earnings Yield | -6.112 |